News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,911 Results
Type
Article (43352)
Company Profile (270)
Press Release (692272)
Multimedia
Podcasts (91)
Webinars (21)
Section
Business (206096)
Career Advice (2199)
Deals (35732)
Drug Delivery (130)
Drug Development (82108)
Employer Resources (176)
FDA (16651)
Job Trends (15102)
News (349132)
Policy (33020)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2656)
Accelerated approval (46)
Adcomms (27)
Allergies (171)
Alliances (50083)
ALS (208)
Alzheimer's disease (1788)
Antibody-drug conjugate (ADC) (430)
Approvals (17004)
Artificial intelligence (652)
Autoimmune disease (263)
Automation (54)
Bankruptcy (363)
Best Places to Work (11734)
BIOSECURE Act (20)
Biosimilars (218)
Biotechnology (178)
Bladder cancer (186)
Brain cancer (70)
Breast cancer (741)
Cancer (5728)
Cardiovascular disease (457)
Career advice (1862)
Career pathing (43)
CAR-T (321)
CDC (56)
Celiac Disease (3)
Cell therapy (857)
Cervical cancer (46)
Clinical research (71020)
Collaboration (2038)
Company closure (5)
Compensation (1345)
Complete response letters (79)
COVID-19 (2771)
CRISPR (106)
C-suite (1084)
Cystic fibrosis (150)
Data (7581)
Decentralized trials (3)
Denatured (28)
Depression (160)
Dermatology (78)
Diabetes (577)
Diagnostics (6995)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (314)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (276)
Earnings (91613)
Editorial (65)
Employer branding (22)
Employer resources (156)
Events (119748)
Executive appointments (1079)
FDA (20290)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1701)
Gene editing (229)
Generative AI (56)
Gene therapy (699)
GLP-1 (1052)
Government (4767)
Grass and pollen (6)
Guidances (404)
Healthcare (19207)
HIV (78)
Huntington's disease (55)
IgA nephropathy (93)
Immunology and inflammation (286)
Immuno-oncology (88)
Indications (176)
Infectious disease (3107)
Inflammatory bowel disease (206)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (287)
Interviews (361)
IPO (16697)
IRA (50)
Job creations (3675)
Job search strategy (1543)
JPM (60)
Kidney cancer (19)
Labor market (96)
Layoffs (567)
Leadership (40)
Legal (8005)
Liver cancer (99)
Longevity (32)
Lung cancer (758)
Lymphoma (422)
Machine learning (59)
Management (61)
Manufacturing (1011)
MASH (179)
Medical device (14035)
Medtech (14136)
Mergers & acquisitions (20263)
Metabolic disorders (1466)
mRNA (199)
Multiple sclerosis (185)
NASH (17)
Neurodegenerative disease (407)
Neuropsychiatric disorders (105)
Neuroscience (3275)
Neurotech (1)
NextGen: Class of 2026 (6632)
Non-profit (4594)
Now hiring (76)
Obesity (686)
Opinion (295)
Ovarian cancer (209)
Pain (249)
Pancreatic cancer (292)
Parkinson's disease (353)
Partnered (33)
Patents (585)
Patient recruitment (649)
Peanut (62)
People (59933)
Pharmaceutical (60)
Pharmacy benefit managers (33)
Phase 1 (22156)
Phase 2 (31277)
Phase 3 (23272)
Pipeline (7976)
Policy (311)
Postmarket research (2586)
Preclinical (9486)
Press Release (66)
Prostate cancer (292)
Psychedelics (52)
Radiopharmaceuticals (322)
Rare diseases (1042)
Real estate (6020)
Recruiting (71)
Regulatory (25479)
Reports (55)
Research institute (2475)
Resumes & cover letters (371)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (177)
Series A (283)
Series B (210)
Service/supplier (11)
Sickle cell disease (109)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (48)
Startups (3684)
State (2)
Stomach cancer (19)
Supply chain (127)
Tariffs (89)
The Weekly (61)
Vaccines (1095)
Venture capital (106)
Weight loss (443)
Women's health (121)
Worklife (21)
Date
Today (53)
Last 7 days (785)
Last 30 days (2696)
Last 365 days (30323)
2026 (10738)
2025 (30402)
2024 (35448)
2023 (40366)
2022 (51523)
2021 (56082)
2020 (54528)
2019 (47088)
2018 (35435)
2017 (32465)
2016 (31901)
2015 (37985)
2014 (31654)
2013 (26710)
2012 (28921)
2011 (29557)
2010 (27603)
Location
Africa (767)
Alabama (92)
Alaska (7)
Arizona (346)
Arkansas (14)
Asia (40067)
Australia (6634)
California (12869)
Canada (3687)
China (1302)
Colorado (552)
Connecticut (559)
Delaware (394)
Europe (87217)
Florida (1936)
Georgia (415)
Hawaii (3)
Idaho (63)
Illinois (1034)
India (89)
Indiana (589)
Iowa (24)
Japan (517)
Kansas (129)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1553)
Massachusetts (9183)
Michigan (356)
Minnesota (701)
Mississippi (6)
Missouri (145)
Montana (34)
Nebraska (29)
Nevada (141)
New Hampshire (85)
New Jersey (3401)
New Mexico (30)
New York (3400)
North Carolina (1638)
North Dakota (9)
Northern California (6415)
Ohio (383)
Oklahoma (24)
Oregon (42)
Pennsylvania (2586)
Puerto Rico (28)
Rhode Island (50)
South America (1136)
South Carolina (85)
South Dakota (2)
Southern California (5070)
Tennessee (208)
Texas (2037)
United States (45556)
Utah (382)
Vermont (1)
Virginia (309)
Washington D.C. (80)
Washington State (1037)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
735,911 Results for "trace ability inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
NextGen
Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access
Trace Neuroscience, a member of
BioSpace
’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options to the ALS community.
March 25, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent
February 2, 2026
·
3 min read
Press Releases
Progentec Diagnostics Advances Ability to Determine Lupus Risk with New Research and OCAST Grant
April 10, 2026
·
2 min read
Genetown
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
March 12, 2024
·
5 min read
Press Releases
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
April 1, 2025
·
3 min read
Press Releases
Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer
December 10, 2025
·
3 min read
Press Releases
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma’s Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
April 21, 2026
·
8 min read
Press Releases
Tubulis Unveils Alco5 Conjugation Platform’s Ability to Expand ADC Payload Scope in Nature Communications
January 21, 2026
·
3 min read
Press Releases
American Aires Inc. Files Legal Proceedings Against Former Executive
March 13, 2026
·
6 min read
Press Releases
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
February 19, 2026
·
5 min read
1 of 73,592
Next
